Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Citing New Data, Pfizer Outlines Case for Booster Shots
Source: New York Times
Citing New Data, Pfizer Outlines Case for Booster Shots
Pfizer’s coronavirus vaccine may become slightly weaker over time, the company reported. But experts said that most people won’t need boosters anytime soon.
By Carl Zimmer, Apoorva Mandavilli and Sharon LaFraniere
July 28, 2021, 3:14 p.m. ET
Pfizer reported on Wednesday that the power of its two-dose Covid vaccine wanes slightly over time, but nonetheless offers lasting and robust protection against serious disease. The company suggested that a third shot could improve immunity, but whether boosters will be widely needed is far from settled, the subject of heated debate among scientists.
So far, federal health officials have said boosters for the general population are unnecessary. And experts questioned whether vaccinated people should get more doses when so many people have yet to be immunized at all.
“There’s not enough evidence right now to support that that is somehow the best use of resources,” said Natalie Dean, a biostatician at Emory University in Atlanta.
Still, the findings raise questions about how well the Pfizer vaccine will prevent infection in the months to come. And with coronavirus cases surging again in many states, the data may influence the Biden administration’s deliberations about delivering boosters for older people.
If third shots are cleared for the general population, the boosters would likely represent a multi-billion-dollar business for Pfizer.
In a study posted online but not yet peer-reviewed or published in a scientific journal, ...
-snip-
Pfizer’s coronavirus vaccine may become slightly weaker over time, the company reported. But experts said that most people won’t need boosters anytime soon.
By Carl Zimmer, Apoorva Mandavilli and Sharon LaFraniere
July 28, 2021, 3:14 p.m. ET
Pfizer reported on Wednesday that the power of its two-dose Covid vaccine wanes slightly over time, but nonetheless offers lasting and robust protection against serious disease. The company suggested that a third shot could improve immunity, but whether boosters will be widely needed is far from settled, the subject of heated debate among scientists.
So far, federal health officials have said boosters for the general population are unnecessary. And experts questioned whether vaccinated people should get more doses when so many people have yet to be immunized at all.
“There’s not enough evidence right now to support that that is somehow the best use of resources,” said Natalie Dean, a biostatician at Emory University in Atlanta.
Still, the findings raise questions about how well the Pfizer vaccine will prevent infection in the months to come. And with coronavirus cases surging again in many states, the data may influence the Biden administration’s deliberations about delivering boosters for older people.
If third shots are cleared for the general population, the boosters would likely represent a multi-billion-dollar business for Pfizer.
In a study posted online but not yet peer-reviewed or published in a scientific journal, ...
-snip-
Read more: https://www.nytimes.com/2021/07/28/health/pfizer-booster-shots.html?unlocked_article_code=AAAAAAAAAAAAAAAACEIPuonUktbfqohkT1UZCybVUNEjsh3BnfbO0rEmw3X5KzOJRCwH1OQSH5PG-1vIYeArQeoP6AmhZY0LNq4zFrs1x_VDPkdpRk73_5DZx58Mf2BootvuGz5r0sOIDe5p-nqzYzXkdrp0mu3jsUvMeCK9DvykpH4kLAxmqZNifEj7miBbg_eYTZMmn4V2zvwjBZhlRDkfZynsvvDgCBl2Ot_ufQiLo0BtGLkfAWeP6Ibav7EQcwxSCUbERWd84gs-6dBcPNAWPsXvPhPBdlhjawJRcZnsXnmZNdM&smid=url-share
1 replies
= new reply since forum marked as read
= new reply since forum marked as read
